University of Connecticut researchers found that repeated exposure to cannabinol, or CBN, produced tolerance and signs of physical dependence in mice.
The findings appear in the November issue of Drug and Alcohol Dependence. They matter because CBN is widely promoted as a mild, plant-derived sleep product even though researchers know little about its long-term effects in people.
Steven Kinsey, a professor in UConn’s Elisabeth DeLuca School of Nursing, said consumers should understand that repeated use may carry risks. Lead author Olivia Vanegas said therapeutic claims about minor cannabinoids have moved ahead of the evidence on repeated use.
What CBN Did in the Mouse Experiments
CBN occurs naturally in cannabis alongside THC and CBD. It is generally considered less psychoactive than THC, but the UConn team found that it activates some of the same biological pathways.
Mice receiving repeated twice-daily administration of CBN became less responsive to several of the compound’s effects, a pattern consistent with tolerance.
When researchers administered a drug that blocks cannabinoid receptors, the mice showed withdrawal-related head twitches, paw tremors, and increased struggling.
The researchers also observed possible benefits. CBN showed anti-inflammatory activity, including at lower doses that did not produce psychoactive effects. During a simulated bacterial challenge, however, CBN weakened part of the body’s defense response.
Why the Connecticut Findings Matter for Cannabis Consumers
The study does not prove that CBN causes dependence or withdrawal in people. Mice process drugs differently from humans, and commercial sleep products vary in dose, formulation, and frequency of use.
The findings still give consumers a reason to read CBN marketing carefully. A product described as natural or non-intoxicating can still interact with cannabinoid receptors, and the long-term safety of nightly use remains unknown.
That uncertainty is especially relevant for people who already live with cannabis use disorder, take other sedating substances, or use sleep products to manage anxiety, trauma symptoms, or chronic insomnia. A clinician can help identify safer treatment options and check for interactions.
When Sleep Aid Use Signals a Need for Rehab Support
Occasional curiosity about CBN is not the same as addiction. Concern becomes more appropriate when someone needs increasing amounts to sleep, feels unwell after skipping a dose, keeps using despite problems, or cannot cut back after deciding to stop.
Those patterns can point to dependence or a broader substance use issue, particularly when CBN is combined with cannabis, alcohol, or other sleep medications. A professional assessment can determine whether outpatient counseling, dual diagnosis care, or another rehab service would help.
People comparing care options can use Rehab.com to review treatment levels and find programs that match their substance use history, mental health needs, insurance coverage, and location. You can also call
800-985-8516
( 
Sponsored Helpline )
to get in contact with a treatment advisor.
As the UConn researchers cautioned, CBN may still have therapeutic value, but buyers should wait for stronger human evidence before treating it as a harmless nightly sleep aid.
